Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Go back to Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
(NASDAQ: CADL) Delayed: 12.22 -0.38 (3.02%)
Previous Close $12.60    52 Week High
Open $12.52    52 Week Low
Day High $12.78    P/E N/A 
Day Low $12.20    EPS
Volume 438,976